Literature DB >> 9929376

Lipid-induced organization of a primary amphipathic peptide: a coupled AFM-monolayer study.

N Van Mau1, V Vié, L Chaloin, E Lesniewska, F Heitz, C Le Grimellec.   

Abstract

To better understand the nature of the mechanism involved in the membrane uptake of a vector peptide, the interactions between dioleoylphosphatidylcholine and a primary amphipathic peptide containing a signal peptide associated with a nuclear localization sequence have been studied by isotherms analysis of mixed monolayers spread at the air-water interface. The peptide and the lipid interact through strong hydrophobic interactions with expansion of the mean molecular area that resulted from a lipid-induced modification of the organization of the peptide at the interface. In addition, a phase separation occurs for peptide molar fraction ranging from about 0.08 to 0.4 Atomic force microscopy observations made on transferred monolayers confirm the existence of phase separation and further reveal that mixed lipid-peptide particles are formed, the size and shape of which depend on the peptide molar fraction. At low peptide contents, round-shaped particles are observed and an increase of the peptide amount, simultaneously to the lipidic phase separation, induces morphological changes from bowls to filamentous particles. Fourier transform infrared spectra (FTIR) obtained on transferred monolayers indicate that the peptide adopts a beta-like structure for high peptide molar fractions. Such an approach involving complementary methods allows us to conclude that the lipid and the peptide have a nonideal miscibility and form mixed particles which phase separate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9929376     DOI: 10.1007/s002329900488

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  8 in total

1.  Detection of peptide-lipid interactions in mixed monolayers, using isotherms, atomic force microscopy, and fourier transform infrared analyses.

Authors:  V Vié; N Van Mau; L Chaloin; E Lesniewska; C Le Grimellec; F Heitz
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

2.  Viral membrane penetration: lytic activity of a nodaviral fusion peptide.

Authors:  Andreas Hinz; Hans-Joachim Galla
Journal:  Eur Biophys J       Date:  2005-04-15       Impact factor: 1.733

Review 3.  Comparison between the behavior of different hydrophobic peptides allowing membrane anchoring of proteins.

Authors:  Mustapha Lhor; Sarah C Bernier; Habib Horchani; Sylvain Bussières; Line Cantin; Bernard Desbat; Christian Salesse
Journal:  Adv Colloid Interface Sci       Date:  2014-01-28       Impact factor: 12.984

4.  Coexistence of a two-states organization for a cell-penetrating peptide in lipid bilayer.

Authors:  Thomas Plénat; Sylvie Boichot; Patrice Dosset; Pierre-Emmanuel Milhiet; Christian Le Grimellec
Journal:  Biophys J       Date:  2005-09-30       Impact factor: 4.033

5.  Domain formation in models of the renal brush border membrane outer leaflet.

Authors:  P E Milhiet; C Domec; M C Giocondi; N Van Mau; F Heitz; C Le Grimellec
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

6.  Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions.

Authors:  Lois M Yin; Michelle A Edwards; Jessica Li; Christopher M Yip; Charles M Deber
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

7.  Interactions of the human calcitonin fragment 9-32 with phospholipids: a monolayer study.

Authors:  Kerstin Wagner; Nicole Van Mau; Sylvie Boichot; Andrey V Kajava; Ulrike Krauss; Christian Le Grimellec; Annette Beck-Sickinger; Frédéric Heitz
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

8.  Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles.

Authors:  Chiranjeevi Peetla; Kavitha S Rao; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.